Aipais: March 2026 Monthly Revenue NT$74 Million (Up +16.2% YoY)
Key facts
- Aipais: March 2026 Monthly Revenue NT$74 Million (Up +16.2% YoY)
- Aipais reported a monthly revenue of NT$74 million for March 2026, representing a solid 16.2% year-over-year increase. This indicates positive growth and a strong market position within the biotechnology and medical industry.
- Source: PR Times
- Date: March 1, 2026
Direct answer
Aipais reported a monthly revenue of NT$74 million for March 2026, representing a solid 16.2% year-over-year increase. This indicates positive growth and a strong market position within the biotechnology and medical industry.
- Citation
- Aipais: March 2026 Monthly Revenue NT$74 Million (Up +16.2% YoY) (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
Aipais reported a monthly revenue of NT$74 million for March 2026, representing a solid 16.2% year-over-year increase. This indicates positive growth and a strong market position within the biotechnology and medical industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 13, 2026 at 10:04 (17h 34m after Collected)
Company Name: Aipais
Industry: Biotechnology and Medical
Data Month: 2026-03
Monthly Revenue: 73,755 thousand NTD (NT$74 million)
Year-over-year Change: +16.2%
FAQ
What are the key facts in this article?
Aipais reported a monthly revenue of NT$74 million for March 2026, representing a solid 16.2% year-over-year increase. This indicates positive growth and a strong market position within the biotechnology and medical industry.
What is the direct answer?
Aipais reported a monthly revenue of NT$74 million for March 2026, representing a solid 16.2% year-over-year increase. This indicates positive growth and a strong market position within the biotechnology and medical industry.
What is the source and date?
PR Times: https://openapi.twse.com.tw/revenue/twse-rev-6918-11503 | March 1, 2026